|
CH575014A5
(enExample)
|
1973-05-25 |
1976-04-30 |
Alusuisse |
|
|
JPS5328498Y2
(enExample)
|
1973-08-17 |
1978-07-18 |
|
|
|
US5260203A
(en)
|
1986-09-02 |
1993-11-09 |
Enzon, Inc. |
Single polypeptide chain binding molecules
|
|
BR9204244A
(pt)
|
1992-10-26 |
1994-05-03 |
Cofap |
Ferro fundido cinzento
|
|
KR100371784B1
(ko)
|
1992-12-01 |
2003-07-22 |
프로테인 디자인랩스, 인코포레이티드 |
L-셀렉틴과반응성인인체화된항체
|
|
FR2707189B1
(fr)
|
1993-07-09 |
1995-10-13 |
Gradient Ass |
Procédé de traitement de résidus de combustion et installation de mise en Óoeuvre dudit procédé.
|
|
FR2729855A1
(fr)
|
1995-01-26 |
1996-08-02 |
Oreal |
Utilisation d'un antagoniste de cgrp dans une composition cosmetique, pharmaceutique ou dermatologique et composition obtenue
|
|
US5876950A
(en)
|
1995-01-26 |
1999-03-02 |
Bristol-Myers Squibb Company |
Monoclonal antibodies specific for different epitopes of human GP39 and methods for their use in diagnosis and therapy
|
|
WO1997010354A1
(fr)
|
1995-09-11 |
1997-03-20 |
Kyowa Hakko Kogyo Co., Ltd. |
Anticorps de la chaine alpha du recepteur de l'interleukine 5 humaine
|
|
EP0852951A1
(de)
|
1996-11-19 |
1998-07-15 |
Roche Diagnostics GmbH |
Stabile lyophilisierte pharmazeutische Zubereitungen von mono- oder polyklonalen Antikörpern
|
|
CN1241944A
(zh)
|
1996-12-05 |
2000-01-19 |
乔治敦大学 |
具有抗病毒活性的鼠尾草种类的提取物
|
|
JPH11101542A
(ja)
|
1997-09-29 |
1999-04-13 |
Sanyo Electric Co Ltd |
冷蔵庫
|
|
ES2434961T5
(es)
|
1998-04-20 |
2018-01-18 |
Roche Glycart Ag |
Ingeniería de glicosilación de anticuerpos para mejorar la citotoxicidad celular dependiente del anticuerpo
|
|
NZ507782A
(en)
|
1998-04-30 |
2003-12-19 |
Tanox Inc |
G-CSF receptor agonist antibodies and screening method therefor
|
|
FR2780062B1
(fr)
|
1998-06-17 |
2000-07-28 |
Rhone Poulenc Rorer Sa |
Anticorps monoclonaux diriges contre la proteine g3bp, et leurs utilisations
|
|
EP1088831A4
(en)
|
1998-06-24 |
2003-01-02 |
Chugai Pharmaceutical Co Ltd |
HEMOPOIETIN RECEPTOR PROTEINS
|
|
AU776910B2
(en)
|
1998-12-08 |
2004-09-23 |
Merck Patent Gesellschaft Mit Beschrankter Haftung |
Modifying protein immunogenicity
|
|
EP1176195B1
(en)
|
1999-04-09 |
2013-05-22 |
Kyowa Hakko Kirin Co., Ltd. |
Method for controlling the activity of immunologically functional molecule
|
|
EP2325316B8
(en)
|
1999-06-02 |
2017-04-19 |
Chugai Seiyaku Kabushiki Kaisha |
Novel hemopoietin receptor protein, NR10
|
|
DE60025241T2
(de)
|
1999-09-27 |
2007-01-11 |
Chugai Seiyaku K.K. |
HäMOPOIETINREZEPTOR-PROTEIN, NR12
|
|
CN1326880A
(zh)
|
2000-06-06 |
2001-12-19 |
周伟中 |
双层站台火车站
|
|
US20030096339A1
(en)
|
2000-06-26 |
2003-05-22 |
Sprecher Cindy A. |
Cytokine receptor zcytor17
|
|
DK1325115T3
(en)
|
2000-06-26 |
2016-11-21 |
Zymogenetics Inc |
CYTOKINRECEPTOR ZCYTOR17
|
|
CA2421447C
(en)
|
2000-09-08 |
2012-05-08 |
Universitat Zurich |
Collections of repeat proteins comprising repeat modules
|
|
JP2004526419A
(ja)
|
2000-10-16 |
2004-09-02 |
フィロス インク． |
抗体模倣物および他の結合タンパク質のためのタンパク質骨格
|
|
WO2002077230A1
(fr)
|
2001-03-26 |
2002-10-03 |
Chugai Seiyaku Kabushiki Kaisha |
Variants d'epissage nr10
|
|
EP1754719A3
(en)
|
2001-04-05 |
2007-05-16 |
Immuno-Biological Laboratories Co., Ltd. |
Anti-osteopontin antibody and use thereof
|
|
US20030157561A1
(en)
|
2001-11-19 |
2003-08-21 |
Kolkman Joost A. |
Combinatorial libraries of monomer domains
|
|
ATE401390T1
(de)
|
2002-01-18 |
2008-08-15 |
Zymogenetics Inc |
Zytokin (zcytor17-ligand)
|
|
EP1576112B1
(en)
|
2002-01-18 |
2012-02-29 |
ZymoGenetics, Inc. |
Cytokine receptor zcytor17 multimers
|
|
EP2110434A1
(en)
|
2002-02-25 |
2009-10-21 |
Genentech, Inc. |
Type-1 cytokine receptor GLM-R
|
|
KR101080587B1
(ko)
|
2002-05-01 |
2011-11-04 |
바이엘 파마 악티엔게젤샤프트 |
항응고제로서의 신규 조직 인자 표적화된 항체
|
|
US7579000B2
(en)
|
2002-05-01 |
2009-08-25 |
Bayer Schering Pharma Ag |
Tissue factor targeted antibodies as anticoagulants
|
|
TW200407335A
(en)
|
2002-07-22 |
2004-05-16 |
Chugai Pharmaceutical Co Ltd |
Non-neutralizing antibody to inhibit the inactivation of activated protein C
|
|
KR100499989B1
(ko)
|
2002-12-27 |
2005-07-07 |
네오바이오다임 주식회사 |
아사이알로 α1-산 당단백질에 대한 단일클론 항체, 이 항체를 포함하는 아사이알로 α1-산 당단백질에 대한 단일클론 항체, 이 항체를 포함하는 면역크로마토그래피 스트립 및 이 스트립를 이용한 아사이알로 α1-산 당단백질 측정방법
|
|
US20040223970A1
(en)
|
2003-02-28 |
2004-11-11 |
Daniel Afar |
Antibodies against SLC15A2 and uses thereof
|
|
NZ577166A
(en)
|
2003-03-04 |
2010-10-29 |
Alexion Pharma Inc |
Method of treating autoimmune disease by inducing antigen presentation by tolerance inducing antigen presenting cells
|
|
AU2004223837C1
(en)
|
2003-03-24 |
2012-03-15 |
Zymogenetics, Inc. |
Anti-IL-22RA antibodies and binding partners and methods of using in inflammation
|
|
JP2007527712A
(ja)
|
2004-02-12 |
2007-10-04 |
レキシコン・ジェネティクス・インコーポレーテッド |
新規な遺伝子破壊、これに関する組成物と方法
|
|
KR100624013B1
(ko)
|
2004-06-25 |
2006-09-19 |
주식회사 녹십자홀딩스 |
동결건조된 알부민 비함유 재조합 사람 혈액응고 제 8인자 제제
|
|
CA2572133A1
(en)
|
2004-06-25 |
2006-01-12 |
Medimmune, Inc. |
Increasing the production of recombinant antibodies in mammalian cells by site-directed mutagenesis
|
|
EP1671642A1
(en)
|
2004-12-15 |
2006-06-21 |
Universite D'angers |
Compositions comprising (ant)agonists of oncostatin M (OSM), IL-31 and IFN-gamma for modulating keratinocyte migration and functions via a receptor containing OSMRbeta as a subunit, and applications thereof.
|
|
MX2007007935A
(es)
|
2004-12-28 |
2007-12-06 |
Innate Pharma Sa |
Anticuerpos monoclonales contra nkg2a.
|
|
AU2006207945B2
(en)
|
2005-01-28 |
2012-02-09 |
Zymogenetics, Inc. |
Homogeneous preparations of IL-31
|
|
EP1856150A2
(en)
|
2005-02-14 |
2007-11-21 |
ZymoGenetics, Inc. |
Methods of treating diseases which are mediated by cutaneous lymphocyte antigen positive cells
|
|
CA2594490A1
(en)
|
2005-02-14 |
2006-08-24 |
Zymogenetics Inc. |
Methods of treating skin disorders using an il-31ra antagonist
|
|
PE20061323A1
(es)
|
2005-04-29 |
2007-02-09 |
Rinat Neuroscience Corp |
Anticuerpos dirigidos contra el peptido amiloide beta y metodos que utilizan los mismos
|
|
US8003108B2
(en)
|
2005-05-03 |
2011-08-23 |
Amgen Inc. |
Sclerostin epitopes
|
|
RU2444528C2
(ru)
|
2005-05-06 |
2012-03-10 |
Займоджинетикс, Инк. |
Моноклональные антитела против il-31 и способы применения
|
|
KR101446989B1
(ko)
*
|
2005-05-06 |
2014-10-15 |
지모제넥틱스, 인코포레이티드 |
Ｉｌ-31 단클론성 항체 및 사용법
|
|
CA2636288C
(en)
|
2006-01-10 |
2015-02-24 |
Zymogenetics, Inc. |
Methods of treating pain and inflammation in neuronal tissue using il-31 antagonists
|
|
ES2586825T3
(es)
|
2006-01-12 |
2016-10-19 |
Alexion Pharmaceuticals, Inc. |
Anticuerpos para OX-2/CD200 y usos de los mismos
|
|
PL2004688T5
(pl)
|
2006-03-23 |
2014-09-30 |
Bioarctic Neuroscience Ab |
Ulepszone przeciwciała wobec protofibryli oraz ich zastosowania
|
|
CL2007001665A1
(es)
|
2006-06-08 |
2008-01-18 |
Chugai Pharmaceutical Co Ltd |
Anticuerpo o fragmento del mismo con actividad neutralizante de la proteina nr 10; agente que lo comprende; y su uso para prevenir o tratar una enfermedad inflamatoria.
|
|
US7858756B2
(en)
|
2006-06-15 |
2010-12-28 |
The Board Of Trustees Of The University Of Arkansas |
Monoclonal antibodies that selectively recognize methamphetamine and methamphetamine like compounds
|
|
RU2009111884A
(ru)
|
2006-09-01 |
2010-10-10 |
Займоджинетикс, Инк. (Us) |
Последовательности вариабельных областей моноклональных антител против il-31 и способы использования
|
|
BRPI0720280A2
(pt)
|
2006-12-11 |
2014-01-28 |
Wyeth Corp |
Métodos e composições para tratar e monitorar tratamento de desordens associadas à il-13
|
|
CN101600456A
(zh)
*
|
2006-12-11 |
2009-12-09 |
惠氏公司 |
治疗il-13相关疾病和监测il-13相关疾病治疗的方法和组合物
|
|
DE602008004296D1
(de)
|
2007-02-14 |
2011-02-17 |
Vaccinex Inc |
Humanisierte anti-cd100-antikörper
|
|
PL2059534T3
(pl)
|
2007-02-23 |
2012-09-28 |
Merck Sharp & Dohme |
Przeciwciała Anty-IL-23p19 wytworzone metodą inżynierii genetycznej
|
|
EP2138576A4
(en)
|
2007-03-16 |
2011-02-23 |
Kyowa Hakko Kirin Co Ltd |
ANTI-CLAUDIN-4 ANTIBODY
|
|
GB0708002D0
(en)
|
2007-04-25 |
2007-06-06 |
Univ Sheffield |
Antibodies
|
|
CA2693611A1
(en)
|
2007-07-10 |
2009-01-15 |
F. Hoffmann-La Roche Ag |
Novel formulation
|
|
DK3059246T3
(en)
|
2007-09-26 |
2018-10-01 |
Chugai Pharmaceutical Co Ltd |
Modified constant region of an antibody
|
|
WO2009041621A1
(ja)
|
2007-09-26 |
2009-04-02 |
Chugai Seiyaku Kabushiki Kaisha |
抗il-6レセプター抗体
|
|
MX336725B
(es)
|
2007-09-26 |
2016-01-28 |
Chugai Pharmaceutical Co Ltd |
Metodo de modificacion del punto isoelectrico de anticuerpos medinate la sustitucion de aminoacidos en region de determinacion de complementariedad (cdr).
|
|
BRPI0821110B8
(pt)
|
2007-12-05 |
2021-05-25 |
Chugai Pharmaceutical Co Ltd |
anticorpo de neutralização de anti-nr10/il31ra, composição farmacêutica compreendendo o referido anticorpo e uso do mesmo
|
|
MY185647A
(en)
|
2007-12-05 |
2021-05-27 |
Chugai Pharmaceutical Co Ltd |
Therapeutic agent for pruritus
|
|
LT2796466T
(lt)
|
2007-12-07 |
2018-02-26 |
Zymogenetics, Inc. |
Humanizuotų antikūnų molekulės, specifinės il-31 atžvilgiu
|
|
KR20160062207A
(ko)
|
2008-12-05 |
2016-06-01 |
추가이 세이야쿠 가부시키가이샤 |
항ｎｒ１０ 항체 및 그의 이용
|
|
JP2010210772A
(ja)
*
|
2009-03-13 |
2010-09-24 |
Dainippon Screen Mfg Co Ltd |
液晶表示装置の製造方法
|
|
ES2758827T3
(es)
|
2009-06-17 |
2020-05-06 |
Biomarin Pharm Inc |
Formulaciones para enzimas lisosómicas
|
|
WO2013012022A1
(ja)
|
2011-07-19 |
2013-01-24 |
中外製薬株式会社 |
アルギニンアミドまたはその類似化合物を含む安定なタンパク質含有製剤
|
|
US8790651B2
(en)
*
|
2011-07-21 |
2014-07-29 |
Zoetis Llc |
Interleukin-31 monoclonal antibody
|
|
HRP20181227T1
(hr)
|
2012-09-07 |
2018-10-05 |
Regeneron Pharmaceuticals, Inc. |
Metode za liječenje atopijskog dermatitisa primjenom antagonista il-4r
|
|
EP2970508A4
(en)
|
2013-03-15 |
2016-12-14 |
Permeon Biologics Inc |
GENETICALLY MODIFIED LOADING ANTIBODIES OR ENHANCED ENHANCEMENT ENHANCEMENT TARGETING PROTEIN COMPOSITIONS AND METHODS OF USE
|
|
US9198898B2
(en)
*
|
2013-06-24 |
2015-12-01 |
Tigercat Pharma, Inc. |
Use of NK-1 receptor antagonists in pruritus
|
|
TW201537175A
(zh)
|
2013-06-28 |
2015-10-01 |
Chugai Pharmaceutical Co Ltd |
預測罹患具皮膚搔癢之疾病的患者對ｉｌ－３１拮抗劑之治療的反應之方法
|
|
MA43918A
(fr)
*
|
2015-04-14 |
2018-12-05 |
Chugai Pharmaceutical Co Ltd |
Composition pharmaceutique pour la prã‰vention et/ou le traitement de la dermatite atopique contenant comme principe actif un antagoniste de l'il-31
|
|
GB201703063D0
(en)
|
2017-02-24 |
2017-04-12 |
Arecor Ltd |
Stabilized antibody protein solutions
|
|
WO2018156367A1
(en)
|
2017-02-24 |
2018-08-30 |
Kindred Biosciences, Inc. |
Anti-il31 antibodies for veterinary use
|
|
US10554227B2
(en)
*
|
2017-03-10 |
2020-02-04 |
Western Digital Technologies, Inc. |
Decoding optimization for channel mismatch
|
|
US10493149B2
(en)
|
2017-04-11 |
2019-12-03 |
Kiniksa Pharmaceuticals, Ltd. |
Stable anti-OSMR antibody formulation
|
|
CN112512480B
(zh)
|
2018-05-21 |
2024-10-01 |
中外制药株式会社 |
被封入玻璃容器的冷冻干燥制剂
|
|
EP4062933A4
(en)
|
2019-11-20 |
2023-12-13 |
Chugai Seiyaku Kabushiki Kaisha |
Antibody-containing preparation
|
|
IL300694A
(en)
|
2020-09-01 |
2023-04-01 |
Chugai Pharmaceutical Co Ltd |
A pharmaceutical preparation for the prevention and/or treatment of dialysis pruritus that includes an IL-31 antagonist as an active ingredient
|
|
WO2022113316A1
(ja)
|
2020-11-30 |
2022-06-02 |
マルホ株式会社 |
線維化の進行抑制剤
|
|
KR102902883B1
(ko)
|
2021-12-22 |
2025-12-22 |
추가이 세이야쿠 가부시키가이샤 |
생물 활성이 저하된 항체 배리언트
|